<<
>>

REFERENCES

1. Thong B, Tan TC. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol. 2011;71(5):684-700.

2. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions.

Curr Opin Allerqy Clin Immunol. 2005;5(4):309-316.

3. Macy E. Penicillin and beta-lactam allergy: epidemiology and diagnosis. Curr Allerqy Asthma Rep. 2014;14(11):476.

4. Khan DA, Solensky R. Drug allergy. J Allerqy Clin Immunol. 2010;125(2 suppl 2):126-138.

5. Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: a cohort study. J Allergy Clin Immunol. 2014;133(3):790-796.

6. Chiriac AM, Banerji A, Gruchalla RS, et al. Controversies in drug allergy: drug allergy pathways. J Allergy Clin Immunol Pract. 2019;7:46-60.

7. Phillips E, Mallal S. Drug hypersensitivity in HIV. Curr Opin Allergy Clin Immunol. 2007;7(4):324-330.

8. Strom BL, Schinnar R, Apter AJ, et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. NEngl JMed. 2003;349(17):1628-1635.

9. Wood RA, Camargo CAJr, Lieberman P, et al. Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States. J Allergy Clin Immunol. 2014;133(2):461.

10. Valent P, Klion AD, Horny HP, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol. 2012;130(3):607.e9-612.e9

11. Metzgeroth G, Walz C, Erben P, et al. Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome - a phase-II study. Br JHaematol. 2008;143(5):707- 715.

12. Roufosse FE, Kahn JE, Gleich GJ, et al. Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes. J Allergy Clin Immunol. 2013;131(2):461.e5-467.e5.

13. Strati P, Cortes J, Faderl S, Kantarjian H, Verstovsek S. Long-term follow-up of patients with hypereosinophilic syndrome treated with alemtuzumab, an anti-CD52 antibody. Clin Lymphoma Myeloma Leuk. 2013;13(3):287-291.

14. Bernstein JA, Lang DM, Khan DA, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2013;133(5):1270.e66-1277.e66

<< | >>
Source: Ancha S., Auberle C., Cash D., Harsh M., Hickman J., Kounga C.. The Washington Manual of Medical Therapeutics, 37th edition, LWW, 2022. —1250p.. 1250
More medical literature on Medic.Studio

More on the topic REFERENCES:

  1. Contents
  2. Dashboard of Indicators and Composite Indices
  3. Contents
  4. REVIEW OF FORENSIC ASSESSMENT INSTRUMENTS
  5. THE STAIRWAY TO THE SKY
  6. Molecular Epidemiology of Bovine Tuberculosis in Uganda
  7. Contents
  8. Contents
  9. 2 Husbandry and estate management: statutory standards
  10. Diagnosis of Bovine Tuberculosis in Zambia